Clinical studies show that mixing and matching booster vaccines can lead to a more robust immune response.
SDI Productions/E+ via Getty Images
On the horizon: A new omicron-focused version of the Moderna vaccine that may offer longer protection and a stronger immune response.
Fewer people reported needing to miss work after their booster, compared to their second dose.
The Novavax COVID vaccine is now available in Australia. What makes it different from the other vaccines? And why are some people waiting for it to get vaccinated?
CORBEVAX uses recombinant DNA technology that many countries already have the infrastructure to produce.
Artis777 via iStock/Getty Images Plus
CORBEVAX is anticipated to significantly expand vaccine access to people in low- and middle-income countries.
Beset by delays, this vaccine is becoming available when low-income countries are desperately short of doses.
By the time Australia is ready to deliver Novavax, we may well have completed most of the vaccine rollout with AstraZeneca, Pfizer and Moderna. That doesn’t mean Novavax won’t play an important role.
While it’s potentially promising, there’s not enough information yet to determine if the vaccine is safe and effective.
One of this and one of that might be a good strategy to coronavirus vaccination.
SOPA Images/LightRocket via Getty Images
Various companies use different ingredients and different delivery systems in their COVID-19 vaccines. Researchers are investigating whether it’s better for individuals to mix what’s available.
A vaccine expert breaks down everything you need to know about the Novavax vaccine.
Charlie J Ercilla / Alamy Stock Photo
Good news for children and young people, bad news for Johnson & Johnson.
The end is in sight.
The anticipated arrival of two new vaccines can boost the morale of those worried about the wait for their dose.
A COVID-19 vaccine is administered at a clinic at Olympic Stadium in Montréal on March 1, 2021, marking the beginning of mass vaccination in the Province of Québec based on age.
THE CANADIAN PRESS/Paul Chiasson
With four COVID-19 vaccines approved for use in Canada, it’s time to answer FAQs about efficacy, immunity, eradication and variants.
Australia should pivot to a high-efficacy vaccine like Pfizer or Novavax to give us the best chance of achieving herd immunity.
Vaccine developers pledge to create boosters that can better handle the new variants of the virus, and new data gives reassurance on the Oxford vaccine.
Both vaccines appear to reduce the risk of developing COVID-19, and so could be approved later this year.
Study shows that the Novavax vaccine is effective against the dominant variant of COVID-19 in South Africa.
Jakub Porzycki/NurPhoto via Getty Images
The results indicate that the vaccine efficacy in the UK was 89% for individuals who received at least two doses of vaccine. In South Africa, the vaccine efficacy was 60% in people without HIV.
The Novavax vaccine is the first that provides objective scientific evidence that it can protect people against the variant virus circulating in South Africa.
The race is on to develop a vaccine for the COVID-19 coronavirus. Australian researchers are leading several major clinical trials that might help bring an end to the deadly disease.
A potential vaccine for coronavirus is undergoing a human trial in Australia. It’s based on a vaccine that was already in development for influenza, and has shown promise in animal studies.